JP2024501919A5 - - Google Patents
Info
- Publication number
- JP2024501919A5 JP2024501919A5 JP2023532700A JP2023532700A JP2024501919A5 JP 2024501919 A5 JP2024501919 A5 JP 2024501919A5 JP 2023532700 A JP2023532700 A JP 2023532700A JP 2023532700 A JP2023532700 A JP 2023532700A JP 2024501919 A5 JP2024501919 A5 JP 2024501919A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- flumazenil
- naltrexone
- administered
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020904390 | 2020-11-27 | ||
| AU2020904390A AU2020904390A0 (en) | 2020-11-27 | Compositions and methods | |
| PCT/AU2021/051413 WO2022109677A1 (en) | 2020-11-27 | 2021-11-26 | Compositions comprising flumazenil and naltrexone and methods for use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024501919A JP2024501919A (ja) | 2024-01-17 |
| JP2024501919A5 true JP2024501919A5 (cg-RX-API-DMAC7.html) | 2024-11-12 |
Family
ID=81753640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023532700A Pending JP2024501919A (ja) | 2020-11-27 | 2021-11-26 | フルマゼニルおよびナルトレキソンを含む組成物ならびにその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12521401B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4251168A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024501919A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230110793A9 (cg-RX-API-DMAC7.html) |
| CN (2) | CN116648246A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2021388076B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3201498A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL303117A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022109677A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025106574A1 (en) * | 2023-11-14 | 2025-05-22 | Aardwolf Therapeutics, Inc. | Flumazenil for treating post-traumatic stress disorder and anxiety |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008538748A (ja) | 2005-04-07 | 2008-11-06 | ハイシアム， インコーポレイテッド | 不安、物質乱用及び依存の予防のための改良型方法及び組成物 |
| JP2009517393A (ja) * | 2005-11-28 | 2009-04-30 | オレキシジェン・セラピューティクス・インコーポレーテッド | 不安症の治療方法 |
| ES2289935B1 (es) | 2006-07-14 | 2008-12-16 | Juan Jose Legarda Ibañez | Empleo de flumazenilo en la elaboracion de un medicamento para el tratamiento de la patologia depresiva. |
| US9283212B2 (en) * | 2009-02-20 | 2016-03-15 | Palmaya Pty Ltd | Pharmaceutical preparation and delivery system |
| US20150111916A9 (en) * | 2010-04-29 | 2015-04-23 | Annette Channa Toledano | Treatment of pain using a composition of opioid/Toll-like receptor 4 antagonists and dextro enantiomers thereof |
| WO2014120936A2 (en) * | 2013-01-30 | 2014-08-07 | Pharmorx Therapeutics, Inc. | Treatments for depression and other diseases with a low dose agent |
| WO2014186824A1 (en) * | 2013-05-20 | 2014-11-27 | Palmaya Pty Ltd | Treatment of neurological and other disorders |
| WO2015054730A1 (en) * | 2013-10-14 | 2015-04-23 | Palmaya Pty Ltd | Compositions and methods of administering same |
| WO2020181340A1 (en) * | 2019-03-14 | 2020-09-17 | Palmaya Pty Ltd | Treatment of inflammatory diseases of the central nervous system |
-
2021
- 2021-11-26 EP EP21895955.9A patent/EP4251168A4/en active Pending
- 2021-11-26 JP JP2023532700A patent/JP2024501919A/ja active Pending
- 2021-11-26 AU AU2021388076A patent/AU2021388076B2/en active Active
- 2021-11-26 CN CN202180078969.9A patent/CN116648246A/zh active Pending
- 2021-11-26 IL IL303117A patent/IL303117A/en unknown
- 2021-11-26 US US18/039,150 patent/US12521401B2/en active Active
- 2021-11-26 CA CA3201498A patent/CA3201498A1/en active Pending
- 2021-11-26 WO PCT/AU2021/051413 patent/WO2022109677A1/en not_active Ceased
- 2021-11-26 KR KR1020237021602A patent/KR20230110793A9/ko active Pending
- 2021-11-26 CN CN202610170303.0A patent/CN121695144A/zh active Pending
-
2025
- 2025-11-13 AU AU2025267401A patent/AU2025267401A1/en active Pending
- 2025-12-16 US US19/422,283 patent/US20260102405A1/en active Pending